Ownership history in Candriam S.C.A. · 37 quarters on record
This page tracks every 13F SEC filing in which Candriam S.C.A. reported a position in PTC THERAPEUTICS INC (PTCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 146,265 | -2,330 | -1.6% | 0.05% | $9.0M | $61.37 |
| 2025 Q2 | REDUCED | 148,595 | -10,504 | -6.6% | 0.04% | $7.3M | $48.84 |
| 2025 Q1 | REDUCED | 159,099 | -1,010 | -0.6% | 0.05% | $8.1M | $50.96 |
| 2024 Q4 | REDUCED | 160,109 | -8,111 | -4.8% | 0.04% | $7.2M | $45.14 |
| 2024 Q3 | ADDED | 168,220 | +1,172 | +0.7% | 0.04% | $6.2M | $37.10 |
| 2024 Q1 | REDUCED | 167,048 | -124,604 | -42.7% | 0.03% | $4.9M | $29.09 |
| 2023 Q4 | UNCHANGED | 291,652 | — | 0% | 0.06% | $8.0M | $27.56 |
| 2023 Q3 | UNCHANGED | 291,652 | — | 0% | 0.05% | $6.5M | $22.41 |
| 2023 Q2 | ADDED | 291,652 | +14,000 | +5.0% | 0.09% | $11.9M | $40.67 |
| 2023 Q1 | ADDED | 277,652 | +75,000 | +37.0% | 0.09% | $12.4M | $48.44 |
As of 2025 Q4 — sorted by position size